Joseph Donahue, most recently head of global sales and president of Lion Bioscience’s US subsidiary, has left the company, BioInform has learned. A company spokeswoman said that a replacement has not yet been named. Donahue joined Lion in 2003 as president of its North American operations. In October 2004, he was appointed co-CEO of the company, along with Thure Etzold. In November, Lion’s supervisory board removed Donahue from the executive board and appointed Etzold CEO and Peter Willinger CFO.
Joseph Donahue, Thure Etzold, Peter Willinger
Jan 17, 2005